The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
J Neuroimmunol
; 366: 577842, 2022 05 15.
Article
in En
| MEDLINE
| ID: mdl-35339941
ABSTRACT
Various neurological complications have been described in COVID-19 patients, especially Guillain-Barre syndrome (GBS). The underlying mechanisms on the association between SARS-CoV-2 infection and GBS remain unclear, but several hypotheses have been proposed. It seems that post-SARS-CoV-2 GBS shares many characteristics with classic post-infectious GBS; however, it may occur in sedated and intubated patients hospitalized in the intensive care unit for SARS-CoV-2 acute respiratory distress syndrome, which presents challenges in the diagnosis and treatment of GBS. In this study, we describe three cases of post-SARS-CoV-2 GBS that were hospitalized in the intensive care unit.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Guillain-Barre Syndrome
/
COVID-19
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
J Neuroimmunol
Year:
2022
Document type:
Article
Affiliation country:
France